Stomach
The Latest
When gut-brain disorders affect eating in adults
-
by Doug Brunk
"Restrictive eating in DGBI is common beyond specialist clinics and highlights the need for integrated multidisciplinary care."
ED drugs tied to lower gastric cancer risk
-
by Kerri Miller
Large retrospective study finds 30% reduction in gastric malignancy among men taking erectile dysfunction medications.
Gastric microbiome shifts track H pylori virulence
-
by Kerri Miller
Pathogenic bacterial genotypes correlate with distinct microbial communities; overall α-diversity is unchanged, but virulent strains show greater diversity within subgroups as atrophy progresses
Exercise patterns and GI cancer risk
-
by Kerri Miller
Consistently meeting—but not exceeding—recommended activity levels offers maximal protection against digestive cancers, new research suggests.
Bariatric surgery vs GLP-1s: GERD risk
-
by Kerri Miller
Propensity-matched analysis of over 80,000 patients reveals bariatric surgery nearly doubles five-year esophageal complication rates compared with GLP-1 RA therapy.
GLP-1s and tirzepatide: Similar GI risk
-
by Kerri Miller
Real-world data show similar rates of severe GI events with semaglutide, dulaglutide, and tirzepatide, reinforcing comparable safety across agents in routine care.
'Don’t take shortcuts,' endoscopy researcher advises
-
by Jennifer Lubell
Dr. Jovani compared two different types of needles for tissue acquisition with endoscopic ultrasound.
AI in gastroenterology and endoscopy
-
by Gyanprakash A. Ketwaroo, MD, MSc, Yuvaraj Singh, MD, Alessandro Colletta, MD, Dennis L. Shung, MD, MHS, PhD
AI tools that were once conceptual are now entering everyday practice,
Do quadruple therapies beat triple for H. pylori?
-
by Kerri Miller
Concomitant and bismuth quadruple regimens provided substantially higher eradication rates than triple therapy without an adherence penalty.
New data tie GLP-1 therapies to GERD
-
by Jennifer Ford
"These potential risks should be weighed against the established clinical benefits of this drug class."
GLP-1 receptor agonist use in gastrointestinal endoscopy: A review of current evidence and guidelines
-
by Sitharthan Sekar, MD, Nikiya Asamoah, MD
Improving care for sexual and gender minority patients with disorders of gut-brain interaction
-
by Kara J. Jencks, MD, Christopher Velez, MD
Avoid getting stuck: A practical guide to managing chronic constipation
-
by Hamza Salim, DO, Anni Chowdhury, DO, Lavanya Viswanathan, MD, MS
How to discuss lifestyle modifications in MASLD
-
by Newsha Nikzad, MD, Daniel J. Huynh, BS, Nikki Duong, MD
Medical, endoscopic, and surgical management of gastroesophageal reflux disease
-
by Patrick Chang, MD, Supisara Tintara, MD, Jennifer Phan, MD
Navigating ethical and clinical considerations relating to percutaneous gastrostomy (PEG) tubes
-
by Emily Seltzer, DO, MS, Antoinette Pusateri, MD, Anh D. Nguyen, MD, Ellen Stein, MD, AGAF
A paradigm shift in evaluating and investigating the etiology of bloating
-
by Rajan Singh, PhD, Baharak Moshiree, MD, AGAF
Advances in pancreaticobiliary disease interventions: More options and better outcomes
-
by Allison R. Schulman, MD, MPH
Establishing an advanced endoscopy practice: Tips for trainees and early faculty
-
by A. Samad Soudagar, MD, Mohammad Bilal, MD, FACP
Navigating your childcare options in a post-COVID world
-
by Kelly E. Hathorn, MD, David W. Creighton, MD
Immune checkpoint inhibitor–related gastrointestinal adverse events
-
by Joshua Kwon, MD, Paul T. Kröner, MD, MSc
Why I decided to get an MBA after becoming a private practice gastroenterologist
-
by Vasu Appalaneni, MD, MBA
Weight loss management ... a new frontier?
-
by Gyanprakash A. Ketwaroo, MD, MSc, GI and Hepatology News